NCT01085734

Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion

A 6-Month, Single Site, Masked, Randomized,Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Maturi, Raj K., M.D., P.C. · Individual
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Comparative study to see if treating with Osurdex in addition to Avastin in patients with retinal vein occlusions helps increased visual acuity outcomes

Conditions

• Retinal Vein Occlusions

Interventions

Type	Name	Description
DRUG	Avastin	1.25mg intravitreally
DRUG	Osurdex	0.7mg intravitreally
DRUG	Avastin	1.25mg intravitreally

Timeline

• Start date: 2010-03-01
• Primary completion: 2011-10-01
• Completion: 2011-10-01
• First posted: 2010-03-12
• Last updated: 2014-04-21
• Results posted: 2014-04-21

Locations

1 site across 1 country: United States